drugset / Trial / NCT00642096

Factorial Study of Metoprolol Succinate TOPROL-XL (324A)

NCT00642096

Phase 3 Completed 1900 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this research study is to determine if treatment with the combination of metoprolol succinate and hydrochlorothiazide is more effective at lowering blood pressure than treatment with either of the two drugs alone. The study will also determine which combined doses of metoprolol succinate and hydrochlorothiazide are most effective at lowering blood pressure (without unacceptable side effects), and whether it is possible to combine both drugs in a single tablet to simplify blood pressure treatment.

Timeline

Start
2003-06
Primary completion
2004-07
Completion
2004-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrochlorothiazide Unknown
Subject Metoprolol Other / unclassified